Skip to main content

Table 2 Clinicopathological features of bladder cancers in HCV-infected patients and non-infected patients

From: Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer

Criteria HCV infected patients Non-HCV patients P value
Age 57.6±8.59 57.9±9.45 NS
Minimum = 36 Minimum = 42
Maximum = 79 Maximum = 80
Sex    
- Male 43 (86%) 42 (84%) NS
- Female 7 (14%) 8 (16%)  
Histopathological type    
- TCC 32 (64%) 19 (38%) p= 0.009
- SCC 18 (36%) 31 (62%)  
Tumour grade    
- Grade I 10 (20%) 26 (52%) p= 0.000
- Grade II 19 (38%) 19 (38%)  
- Grade III 21 (42%) 5 (10%)  
Lymph Nodes (LNs)    
- Negative LNs 38 (76%) 40 (80%) NS
- Positive LNs 12 (24 %) 10 (20%)  
Tumour staging    
- Stage (Ta) 1 (2%) 5 (10%) p= 0.002
- Stage (T1) 12 (24%) 17 (34%)  
- Stage (T2) 13 (26%) 15 (30%)  
- Stage (T3) 12 (24%) 8 (16%)  
- Stage (T4) 12 (24%) 5 (10%)  
Metastases    
- Negative 43 (86%) 42 (84%) NS
- Positive 7 (14%) 8 (16%)  
  1. P= chi square test with significance of p ≤ 0.05.